Mumbai: Roche Pharma India in partnership with Sidney Kimmel Cancer Center (SKCC) – Jefferson Health, Pennsylvania, US and BioQuest Solutions Pvt Ltd has launched an advanced certification programme in molecular oncology (ACMO) to equip oncologists & pathologists in the country with methods of genomic/personalised medicine.
Around 100 healthcare professionals including 70 oncologists and 30 pathologists from across the country will be trained under this programme. Comprising of 14 online modules, the programme spreads over eight months and aims to provide comprehensive, evidence-based updates on personalised medicine.
Underlining the significance of the programme in patient care, V Simpson Emmanuel, Managing Director & CEO, Roche Pharma India, said, “Understanding what makes people different – genetics, environment, lifestyle – is central to shifting the focus of healthcare from treating diseases to delivering the best care for each person throughout their lives. This is the promise of personalised healthcare. Roche is committed to transform cancer care delivery in India by bringing a focus on personalised healthcare to improve patient outcomes. We believe that the advanced certification programme in molecular oncology (ACMO) offered by the Sidney Kimmel Cancer Center – Jefferson Health will help equip our oncologists and pathologists with the subject matter expertise and methods of precision oncology to bring a desired change to individualised patient care.”
Precision oncology is based on using an individual’s genetic profile to make the best therapeutic choice and will help to decipher whether a treatment will be beneficial for the patient or not.
The programme faculty will include professors from various departments affiliated to the Thomas Jefferson University, including oncology, urology, computational medicine, biochemistry and molecular biology. Interspersed with live virtual sessions, the online programme is a case-based, self-learning, interactive certification course.
Dr Annette Mallory Donawa, Assistant Provost, Office of Continuing Professional Development, Thomas Jefferson University from Sydney Kimmel added, “Personalised medicine is an emerging approach for disease treatment and prevention. Jefferson University and Sidney Kimmel Cancer Center have pioneered newer modalities of educational initiatives for physicians and ACMO is aligned with this model. We are very pleased to be associated with the programme and believe clinicians in India would benefit immensely from this course.”